Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
May 08, 2024 07:40 ET
|
Vigil Neuroscience, Inc.
WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of...
MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 Third Quarter
May 08, 2024 07:30 ET
|
MasterCraft Boat Holdings, Inc.
VONORE, Tenn., May 08, 2024 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 third quarter ended March 31, 2024. The...
Kornit Digital Reports First Quarter 2024 Results
May 08, 2024 07:30 ET
|
Kornit Digital Ltd
First quarter revenues of $43.8 million, in line with previous guidanceFirst quarter GAAP net loss of $13.2 million; non-GAAP net loss of $5.3 millionGenerated positive cash flow from operations for...
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
May 08, 2024 07:30 ET
|
InflaRx N.V.
Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the opportunity, the role of C5aR in chronic spontaneous urticaria (CSU) and...
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
May 08, 2024 07:30 ET
|
Cytokinetics, Incorporated
Data Support Advancement to Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 Full Data from the Phase 1 Study to be Presented at a...
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
May 08, 2024 07:30 ET
|
BioRestorative Therapies, Inc
— New therapeutic candidate developed using Company’s patented ThermoStem® platform — — Candidate has potential to serve as an adjuvant to existing pharmaceuticals that are FDA approved and...
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
May 08, 2024 07:30 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin...
Kelly to Participate in the 18th Annual Barrington Research Virtual Spring Investment Conference
May 08, 2024 07:30 ET
|
Kelly Services, Inc.
TROY, Mich., May 08, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced it will participate in the 18th Annual Barrington...
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
May 08, 2024 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment...
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
May 08, 2024 07:30 ET
|
BrainsWay
Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive Adjusted EBITDA and Cash Flow from Operations...